Cantor Fitzgerald Predicts SPRY FY2026 Earnings
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for ARS Pharmaceuticals in a report issued on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer expects that the company will post earnings of ($0.45) per share for the year. The consensus estimate for ARS Pharmaceuticals’ current […]
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for ARS Pharmaceuticals in a report issued on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer expects that the company will post earnings of ($0.45) per share for the year. The consensus estimate for ARS Pharmaceuticals’ current […]
